These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 32924185)

  • 1. CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice.
    Gutiérrez-Muñoz C; Méndez-Barbero N; Svendsen P; Sastre C; Fernández-Laso V; Quesada P; Egido J; Escolá-Gil JC; Martín-Ventura JL; Moestrup SK; Blanco-Colio LM
    FASEB J; 2020 Nov; 34(11):14960-14976. PubMed ID: 32924185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD163
    Mori M; Sakamoto A; Kawakami R; Guo L; Slenders L; Mosquera JV; Ghosh SKB; Wesseling M; Shiraki T; Bellissard A; Shah P; Weinkauf CC; Konishi T; Sato Y; Cornelissen A; Kawai K; Jinnouchi H; Xu W; Vozenilek AE; Williams D; Tanaka T; Sekimoto T; Kelly MC; Fernandez R; Grogan A; Coslet AJ; Fedotova A; Kurse A; Mokry M; Romero ME; Kolodgie FD; Pasterkamp G; Miller CL; Virmani R; Finn AV
    Circ Res; 2024 Jul; 135(2):e4-e23. PubMed ID: 38860377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
    Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.
    Sastre C; Fernández-Laso V; Madrigal-Matute J; Muñoz-García B; Moreno JA; Pastor-Vargas C; Llamas-Granda P; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
    J Cell Mol Med; 2014 Apr; 18(4):721-34. PubMed ID: 24479820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques.
    Habib A; Polavarapu R; Karmali V; Guo L; Van Dam R; Cheng Q; Akahori H; Saeed O; Nakano M; Pachura K; Hong CC; Shin E; Kolodgie F; Virmani R; Finn AV
    Atherosclerosis; 2015 Aug; 241(2):692-700. PubMed ID: 26125411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice.
    Fernández-Laso V; Sastre C; Méndez-Barbero N; Egido J; Martín-Ventura JL; Gómez-Guerrero C; Blanco-Colio LM
    Sci Rep; 2017 Apr; 7():46679. PubMed ID: 28447667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cartilage Oligomeric Matrix Protein Associates With a Vulnerable Plaque Phenotype in Human Atherosclerotic Plaques.
    Hultman K; Edsfeldt A; Björkbacka H; Dunér P; Sundius L; Nitulescu M; Persson A; Boyle JJ; Nilsson J; Hultgårdh-Nilsson A; Bengtsson E; Gonçalves I
    Stroke; 2019 Nov; 50(11):3289-3292. PubMed ID: 31495329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction and metabolic reprogramming induce macrophage pro-inflammatory phenotype switch and atherosclerosis progression in aging.
    Vendrov AE; Lozhkin A; Hayami T; Levin J; Silveira Fernandes Chamon J; Abdel-Latif A; Runge MS; Madamanchi NR
    Front Immunol; 2024; 15():1410832. PubMed ID: 38975335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI.
    Tarin C; Carril M; Martin-Ventura JL; Markuerkiaga I; Padro D; Llamas-Granda P; Moreno JA; García I; Genicio N; Plaza-Garcia S; Blanco-Colio LM; Penades S; Egido J
    Sci Rep; 2015 Nov; 5():17135. PubMed ID: 26616677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice].
    Fernández-Laso V; Sastre C; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Clin Investig Arterioscler; 2015; 27(1):17-25. PubMed ID: 25027757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.
    van Kampen E; Beaslas O; Hildebrand RB; Lammers B; Van Berkel TJ; Olkkonen VM; Van Eck M
    PLoS One; 2014; 9(10):e109024. PubMed ID: 25347070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD163+ macrophages are associated with a vulnerable plaque phenotype in human carotid plaques.
    Bengtsson E; Hultman K; Edsfeldt A; Persson A; Nitulescu M; Nilsson J; Gonçalves I; Björkbacka H
    Sci Rep; 2020 Sep; 10(1):14362. PubMed ID: 32873809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis.
    Guo L; Akahori H; Harari E; Smith SL; Polavarapu R; Karmali V; Otsuka F; Gannon RL; Braumann RE; Dickinson MH; Gupta A; Jenkins AL; Lipinski MJ; Kim J; Chhour P; de Vries PS; Jinnouchi H; Kutys R; Mori H; Kutyna MD; Torii S; Sakamoto A; Choi CU; Cheng Q; Grove ML; Sawan MA; Zhang Y; Cao Y; Kolodgie FD; Cormode DP; Arking DE; Boerwinkle E; Morrison AC; Erdmann J; Sotoodehnia N; Virmani R; Finn AV
    J Clin Invest; 2018 Mar; 128(3):1106-1124. PubMed ID: 29457790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.
    Sato K; Shirai R; Yamaguchi M; Yamashita T; Shibata K; Okano T; Mori Y; Matsuyama TA; Ishibashi-Ueda H; Hirano T; Watanabe T
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice.
    Nogi Y; Nagashima M; Terasaki M; Nohtomi K; Watanabe T; Hirano T
    PLoS One; 2012; 7(4):e35683. PubMed ID: 22536426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage Foam Cell-Targeting Immunization Attenuates Atherosclerosis.
    Wang F; Zhang Z; Fang A; Jin Q; Fang D; Liu Y; Wu J; Tan X; Wei Y; Jiang C; Song X
    Front Immunol; 2018; 9():3127. PubMed ID: 30687328
    [No Abstract]   [Full Text] [Related]  

  • 19. CCN3 Regulates Macrophage Foam Cell Formation and Atherosclerosis.
    Shi H; Zhang C; Pasupuleti V; Hu X; Prosdocimo DA; Wu W; Qing Y; Wu S; Mohammad H; Gerson SL; Perbal B; Klenotic PA; Dong N; Lin Z
    Am J Pathol; 2017 Jun; 187(6):1230-1237. PubMed ID: 28527710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mindin deficiency in macrophages protects against foam cell formation and atherosclerosis by targeting LXR-β.
    Zhang C; Qin JJ; Gong FH; Tong JJ; Cheng WL; Wang H; Zhang Y; Zhu X; She ZG; Xia H; Zhu LH
    Clin Sci (Lond); 2018 Jun; 132(11):1199-1213. PubMed ID: 29695588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.